ResearcherSapienza University of RomeNo recent work listed

Vincenzo Tombolini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5359-9991; OpenAlex author ID A5015515380. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

Hypofractionated intensity-modulated radiotherapy in locally advanced unresectable pancreatic cancer: A pilot study. Last author DOI 10.1016/j.currproblcancer.2019.04.003 ↗
Neoadjuvant strategy as initial treatment in resectable pancreatic cancer: concrete evidence of benefit. Last author PMID 25202043 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Francesca De Felice · 2 shared papers, 2014–2019 · strength 0.16
- Paper Hypofractionated intensity-modulated radiotherapy in locally advanced unresectable pancreatic cancer: A pilot study. DOI 10.1016/j.currproblcancer.2019.04.003 ↗
- Paper Neoadjuvant strategy as initial treatment in resectable pancreatic cancer: concrete evidence of benefit. PMID 25202043 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.